Comments
Commented by Stefan Feulner on December 16th, 2024 | 07:15 CET
Ballard Power, F3 Uranium, Nordex – Alternative energies with a clean rebound
While the stock market is still shining, it is dark in Germany - not referring to the current government still in office but to the weather. In addition to the fact that the sun is hardly showing, the wind is also blowing even weaker than usual. As a result, significantly less energy is being generated during the dark doldrums. Gas and coal-fired power plants have to step in here, but their electricity production is considerably more expensive. A clean alternative embraced by the rest of the world is nuclear energy. While the traffic light coalition took the last reactors off the grid, the expansion of uranium production is being strongly pushed there.
Read
Commented by André Will-Laudien on December 16th, 2024 | 07:00 CET
Bull's eye in 2025: Nuclear energy and hydrogen! Watch out for Nel, Plug Power, First Hydrogen, Mercedes and BMW
The production of hydrogen using nuclear energy is seen as a promising way to create a flexible energy carrier in a climate-neutral manner. Especially in areas where renewable energy sources are insufficient or a continuous power supply is required, hydrogen demonstrates its strengths. The carbon footprint of hydrogen from nuclear energy is comparable to that of renewable sources such as wind and solar since nuclear power plants operate almost emission-free. Unlike wind or solar energy, nuclear power can generate electricity around the clock because it is not dependent on weather conditions. This helps to avoid so-called dark doldrums, such as the one recently experienced in Germany on Friday. In countries such as France and Japan, nuclear energy is already considered an option for hydrogen production to advance the decarbonisation of industries. Which stocks are coming to the fore as a result?
Read
Commented by Juliane Zielonka on December 13th, 2024 | 07:00 CET
Medical milestones from Novo Nordisk, BioNxt and Bayer: New hope for millions of patients
Medical research is currently making remarkable progress in the treatment of serious diseases. Three companies in this field are reporting important developments that could improve the lives of many people: the Danish pharmaceutical company Novo Nordisk is consolidating its leading position in the fight against obesity with a market share of over 30% in GLP-1 drugs and is driving global expansion. At the same time, the Canadian company BioNxt Solutions is developing a groundbreaking MS therapy: an innovative and simple administration could significantly ease the daily medication routine for MS patients. Bayer, in turn, is starting an important study for a novel cancer drug that is expected to be particularly effective against aggressive tumour types due to its unique mechanism of action. The specific benefits offered by the new therapies and how they change patients' lives are factors that investors should consider when making their next investment decisions.
Read
Commented by André Will-Laudien on December 12th, 2024 | 07:30 CET
Find the 100% opportunities for 2025! Rheinmetall, Renk, Globex Mining, C3.ai and Palantir in focus
After a 30% rise in prices in the major indices since the beginning of the year, investors are asking themselves how they can weatherproof their portfolio for 2025. On the one hand, a well-defined stop strategy for overheated high-tech stocks is an option. Therefore, the topic of trailing stops should be studied in more detail and implemented. For new investments, there are always interesting setbacks to get back in on the next party. This scenario currently applies to the defense stocks Renk and Rheinmetall. Globex Mining covers almost the entire range of strategic metals that are indispensable for high-tech and defense manufacturers. Furthermore, some AI stocks like Palantir or C3.ai deserve a critical look. Accumulated profits could quickly disappear again here. We are delving deeper into the analysis.
Read
Commented by Stefan Feulner on December 12th, 2024 | 07:05 CET
MicroStrategy, Thunder Gold, C3.ai – These are the favorites
The 2024 stock market year is coming to an end, and despite all the uncertainties in geopolitics, leading stock indices, Bitcoin, and the precious metal gold are close to their historic highs. While looking at the favorites for the coming year, companies involved in artificial intelligence are expected to continue to perform well. The majority of experts remain bullish on Bitcoin and gold.
Read
Commented by Juliane Zielonka on December 12th, 2024 | 07:00 CET
F3 Uranium, Palantir and Alphabet: How the AI boom is driving demand for nuclear energy and benefiting tech giants
The increasing energy demand for AI applications and data centers is driving the demand for reliable, low-carbon base load supply from nuclear power. This is putting explorers like F3 Uranium in the spotlight of investors. With its PLN project and uranium holdings of up to 30.9% U3O8, the Company is positioning itself as an important raw materials supplier for this development. As an AI specialist, Palantir is benefiting from the current growth in several ways: On the one hand, through new contracts in the defense sector, such as the recent collaboration with Anduril Industries and the contract extension with the US Special Operations Command. On the other hand, the growing demand for a stable energy supply for its computationally intensive applications. Alphabet is investing heavily in its AI infrastructure, with planned spending of USD 50 billion. These investments in data centers and cloud computing require a reliable power supply, which is increasingly to be provided by nuclear power.
Read
Commented by Fabian Lorenz on December 11th, 2024 | 07:45 CET
New hydrogen hype in 2025? Nel ASA, thyssenkrupp nucera, Plug Power, and First Hydrogen
Is nuclear-based hydrogen fueling a comeback for the industry? The growing energy demand for AI and other technologies is straining electricity grids. Shares of First Hydrogen have surged 17% following its announcement to venture into small nuclear reactors for hydrogen production, yet the Company is still valued at less than CAD 20 million. Nel is to build a pilot plant in South Korea to produce hydrogen from surplus nuclear power. However, the valuation of the Norwegian company still seems too high. Plug Power shareholders might face turbulent times in the coming weeks as short-sellers position themselves. By contrast, thyssenkrupp nucera is recommended as a "Buy". Which hydrogen player will take off in 2025?
Read
Commented by Armin Schulz on December 11th, 2024 | 07:30 CET
Super Micro Computer, Power Nickel, Renk – Cash in on megatrends
Global megatrends such as artificial intelligence, raw materials for green technologies, and defense technologies are fundamentally changing markets and societies – and offering enormous opportunities for investors. Companies that address these trends early on can grow disproportionately in the long term and generate significant returns for their shareholders. These technologies are not only shaping the future but also driving the performance of tomorrow's stock market stars. We look at three companies that are benefiting from these megatrends.
Read
Commented by André Will-Laudien on December 11th, 2024 | 07:15 CET
DAX 25,000 and gold at 3,500 next year? Position now with Lufthansa, TUI, Desert Gold, and Barrick Gold
After an extensive stock rally in 2024, many investors are wondering what the New Year 2025 will bring in terms of investments. Hopes are resting, on the one hand, on the upcoming conservative government changes in the US and Germany. There is great confidence in a new supply-side industrial policy flanked by further interest rate reduction measures. Deregulation of bureaucracy and tax relief could usher in a new era of corporate profitability, especially in Germany. This might eventually lead to the return of foreign investments and job creation, replacing the red-green visions of a carbon-neutral 28-hour workweek with full pay. We provide some insights on where and how profits might flow again.
Read
Commented by Stefan Feulner on December 10th, 2024 | 07:30 CET
Novo Nordisk, BioNxt Solutions, Bayer – The market continues to boom
The weight-loss drug market was one of the fastest-growing sectors in the past year and shows no signs of slowing down in 2025. Companies like Novo Nordisk have seen their valuations multiply in recent years, significantly boosting their market capitalization. At the same time, smaller life sciences companies in the second tier, such as those with breakthrough technologies, offer interesting entry opportunities.
Read